Showing results (41-50 of 68) with videos related to
Sort By:
Pageof 7
Statistics in Medicine|October 10, 2012
Key multiplicity issues in clinical drug developmentAlex Dmitrienko, Ralph B D'Agostino, Mohammad F HuqueStatistics in Medicine|July 26, 2024
Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational dataIlya Lipkovich, David Svensson, Bohdana Ratitch, et al.Therapeutic Innovation & Regulatory Science|July 30, 2021
Data-Driven Subgroup Identification in Confirmatory Clinical TrialsPierre Bunouf, Mélanie Groc, Alex Dmitrienko, et al.Journal of Biopharmaceutical Statistics|April 26, 2011
Three methods for constructing parallel gatekeeping procedures in clinical trialsAlex Dmitrienko, Julia N Soulakova, Brian A MillenPharmaceutical Statistics|November 4, 2006
Gatekeeping procedures in dose-response clinical trials based on the Dunnett testAlex Dmitrienko, Walt Offen, Ouhong Wang, et al.Expert Review of Clinical Pharmacology|January 14, 2014
Design and analysis considerations for thorough QT studies employing conventional (10 s, 12-lead) ECG recordingsCharles M Beasley, Alex Dmitrienko, Malcolm I MitchellJournal of Biopharmaceutical Statistics|September 23, 2015
Tradeoff-based optimization criteria in clinical trials with multiple objectives and adaptive designsAlex Dmitrienko, Gautier Paux, Erik Pulkstenis, et al.Journal of Biopharmaceutical Statistics|September 15, 2015
General guidance on exploratory and confirmatory subgroup analysis in late-stage clinical trialsAlex Dmitrienko, Christoph Muysers, Arno Fritsch, et al.Journal of Biopharmaceutical Statistics|November 28, 2017
Multiplicity issues in exploratory subgroup analysisIlya Lipkovich, Alex Dmitrienko, Christoph Muysers, et al.Clinical Trials (London, England)|May 19, 2023
Overview of modern approaches for identifying and evaluating heterogeneous treatment effects from clinical dataIlya Lipkovich, David Svensson, Bohdana Ratitch, et al.Pageof 7